Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02504294
Brief Title: A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

First Submitted : July 20, 2015
First Submitted that Met QC Criteria : July 20, 2015
First Posted : July 21, 2015 (Estimate)

Results First Submitted : May 16, 2018
Results First Submitted that Met QC Criteria : May 16, 2018
Results First Posted : June 13, 2018

Certification/Extension First Submitted : September 7, 2017
Certification/Extension First Submitted that Met QC Criteria : September 20, 2017
Certification/Extension First Posted : September 28, 2017

Last Update Submitted that Met QC Criteria : May 16, 2018
Last Update Posted : June 13, 2018